Diet in Parkinson’s Disease: Critical Role for the Microbiome

Cites (328)

Items 201–328 of 328

1. Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson's disease mice via gut microbiota and metabolites
   Zhou, Zhi-Lan, Jia, Xue-Bing, Sun, Meng-Fei, Zhu, Ying-Li, Qiao, Chen-Meng, Zhang, Bo-Ping, Zhao, Li-Ping, Yang, Qin, Cui, Chun, Chen, Xue et al. · 2019 · Neurotherapeutics
2. Consumption of Dairy Products and Risk of Parkinson's Disease
   Honglei Chen, Éilis J. O’Reilly, Marjorie L. McCullough, C. Rodriguez, Michael A. Schwarzschild, E. E. Calle, Michael J. Thun, Alberto Ascherio · 2007 · American Journal of Epidemiology
3. Inflammasome signaling at the heart of central nervous system pathology
   Swarupa Chakraborty, Deepak Kumar Kaushik, Malvika Gupta, Anirban Basu · 2010 · Journal of Neuroscience Research
4. Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese
   Eng‐King Tan, Celia Ia Choo Tan, Stephanie Man Chung Fook-Chong, S.Y. Lum, Andrea Chai, H. Chung, Hui Shen, Yi Zhao, Mei Lin Teoh, Y. Yih et al. · 2003 · Journal of the Neurological Sciences
5. Oral supplementation with docosahexaenoic acid and uridine-5’-monophosphate increases dendritic spine density in adult gerbil hippocampus
   Sakamoto, Toshimasa, Cansev, Mehmet, Wurtman, Richard J. · 2007 · Brain Research
6. Does Parkinson’s disease start in the gut?
   Arthur Lionnet, Laurène Leclair‐Visonneau, Michel Neunlist, Shigeo Murayama, Masaki Takao, Charles H. Adler, Pascal Derkinderen, Thomas G. Beach · 2017 · Acta Neuropathologica
7. Caffeine and risk of Parkinson’s disease in a large cohort of men and women
   Palacios, Natalia, Gao, Xiang, McCullough, Marjorie L., Schwarzschild, Michael A., Shah, Roma, Gapstur, Susan, Ascherio, Alberto · 2012 · Movement Disorders
8. Regulation of Intestinal Immune Responses through TLR Activation: Implications for Pro- and Prebiotics
   Sander de Kivit, Mary C. Tobin, Christopher B. Forsyth, Ali Keshavarzian, ALAN L. LANDAY · 2014 · Frontiers in Immunology
9. Polyphenols in Parkinson’s Disease: A Systematic Review of In Vivo Studies
   Małgorzata Kujawska, Jadwiga Jodynis‐Liebert · 2018 · Nutrients
10. Talking microbes: When gut bacteria interact with diet and host organs
    Patrice D. Cani, Amandine Everard · 2015 · Molecular Nutrition & Food Research
11. Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects
    Traba, Javier, Kwarteng-Siaw, Miriam, Okoli, Tracy C., Li, Jessica, Huffstutler, Rebecca D., Bray, Amanda, Waclawiw, Myron A., Han, Kim, Pelletier, Martin, Sauve, Anthony A. et al. · 2015 · Journal of Clinical Investigation
12. Lessons from the rotenone model of Parkinson's disease
    J. Timothy Greenamyre, Jason R. Cannon, Robert E. Drolet, Pier G. Mastroberardino · 2010 · Trends in Pharmacological Sciences
13. Role of Diet and Nutritional Supplements in Parkinson’s Disease Progression
    Laurie K. Mischley, Richard C. Lau, Rachel D. Bennett · 2017 · Oxidative Medicine and Cellular Longevity
14. Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China
    Li, Chunxiao, Cui, Li, Yang, Yimin, Miao, Jing, Zhao, Xiuzhen, Zhang, Jingdian, Cui, Guohong, Zhang, Ying · 2019 · Frontiers in Molecular Neuroscience
15. Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
    Chuansheng Guo, Shujun Xie, Zhexu Chi, Jinhua Zhang, Yangyang Liu, Li Zhang, Mingzhu Zheng, Xue Zhang, Dajing Xia, Yuehai Ke et al. · 2016 · Immunity
16. Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection
    Nicolas Guillermo Bazan · 2009 · Prostaglandins Leukotrienes and Essential Fatty Acids
17. Inflammatory Bowel Disease and Parkinson’s Disease: A Nationwide Swedish Cohort Study
    Petra Weimers, Jonas Halfvarson, Michael Charles Sachs, Rachel J. Saunders-Pullman, Jonas Filip Ludvigsson, Inga Peter, Johan M. Burisch, Ola Olén · 2018 · Inflammatory Bowel Diseases
18. Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults
    Gregory E. Miller, Phillip A. Engen, Patrick Martin Gillevet, Maliha W. Shaikh, Masoumeh Sikaroodi, Christopher B. Forsyth, Ece Mutlu, Ali Keshavarzian · 2016 · PLoS ONE
19. Parkinson’s Disease and the Gastrointestinal Microbiome
    Lubomski, Michal, Tan, Ai Huey, Lim, Shen-Yang, Holmes, Andrew J., Davis, Ryan L., Sue, Carolyn M. · 2020 · Journal of Neurology
20. Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer’s Disease Brain
    Yuhai Zhao, Lin Cong, Vivian R. Jaber, Walter J. Lukiw · 2017 · Frontiers in Immunology
21. Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives
    K. Knudsen, K. Krogh, K. Østergaard, P. Borghammer · 2017 · Movement Disorders
22. Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
    Noelker, Carmen, Morel, Lydie, Lescot, Thomas, Osterloh, Anke, Alvarez-Fischer, Daniel, Breloer, Minka, Henze, Carmen, Depboylu, Candan, Skrzydelski, Delphine, Michel, Patrick P. et al. · 2013 · Scientific Reports
23. Mitochondrial Dysfunction in Parkinson's Disease
    Jianhui Zhu, Charleen T. Chu · 2010 · Journal of Alzheimer s Disease
24. Starke Belege: Parkinson könnte im Verdauungstrakt beginnen
    2017 · Fortschritte der Neurologie · Psychiatrie
25. Inflammasome activation and innate immunity in A lzheimer's disease
    Michael Thomas Heneka · 2016 · Brain Pathology
26. The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus
    O’Leary, Olivia F., Ogbonnaya, Ebere S., Felice, Daniela, Levone, Brunno R., C. Conroy, Lorraine, Fitzgerald, Patrick, Bravo, Javier A., Forsythe, Paul, Bienenstock, John, Dinan, Timothy G. et al. · 2018 · European Neuropsychopharmacology
27. Diet and Parkinson's disease: A potential role of dairy products in men
    Honglei Chen, Shumin M. Zhang, Miguel Ángel Hernán, Walter Churchill Willett, Alberto Ascherio · 2002 · Annals of Neurology
28. The Gut and Parkinson's Disease—A Bidirectional Pathway
    Susanne Fonseca Santos, Hadassa Loth de Oliveira, Elizabeth Sumi Yamada, Bianca Cruz Neves, Antônio Pereira · 2019 · Frontiers in Neurology
29. Consumption of milk and calcium in midlife and the future risk of Parkinson disease
    M. Park, G. Webster Ross, Helen Petrovitch, Lon R. White, Kamal Masaki, J. S. Nelson, Caroline M. Tanner, J. David Curb, Patricia Lanoie Blanchette, Robert D. Abbott · 2005 · Neurology
30. How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology
    Per Borghammer · 2017 · Movement Disorders
31. Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece
    Andreas Kyrozis, Apostolia Ghika, Panos Stathopoulos, Dimitrios Vassilopoulos, Dimitrios Trichopoulos, Antonia Trichopoulou · 2013 · European Journal of Epidemiology
32. Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review
    Bodnaruc, Alexandra M., Prud’homme, Denis, Blanchet, Rosanne, Giroux, Isabelle · 2016 · Nutrition & Metabolism
33. Activation of Nrf2 pathway and inhibition of NLRP3 inflammasome activation contribute to the protective effect of chlorogenic acid on acute liver injury
    Ameng Shi, Haitao Shi, Yan Wang, Xin Liu, Yan Cheng, Hong Li, Hongli Zhao, Shuangni Wang, Lei Dong · 2017 · International Immunopharmacology
34. A New Treatment Strategy for Parkinson's Disease through the Gut–Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway
    Kim, Dong Seok, Choi, Ho-Il, Wang, Yun, Luo, Yu, Hoffer, Barry J., Greig, Nigel H. · 2017 · Cell Transplantation
35. The risk of Parkinson’s disease in inflammatory bowel disease: A systematic review and meta-analysis
    Zhu, Feng, Li, Chuling, Gong, Jianfeng, Zhu, Weiming, Gu, Lili, Li, Ning · 2019 · Digestive and Liver Disease
36. Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity
    Jena, Prasant Kumar, Sheng, Lili, Di Lucente, Jacopo, Jin, Lee‐Way, Maezawa, Izumi, Wan, Yu‐Jui Yvonne · 2018 · The FASEB Journal
37. Parkinson’s disease and bacteriophages as its overlooked contributors
    George V. Tetz, Stuart M. Brown, Yuhan Hao, Victor Tetz · 2018 · Scientific Reports
38. Low BDNF is associated with cognitive impairments in patients with Parkinson’s disease
    Yu Wang, Hong Shu Liu, Benshu Zhang, Jair C. Soares, Xiang Yang Zhang · 2016 · Parkinsonism & Related Disorders
39. Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1 β Production
    József Tőzsér, Szilvia Benkő · 2016 · Mediators of Inflammation
40. Impact of omega-3 fatty acids in Parkinson's disease
    M. Bousquet, Frédéric Calon, Francesca Cicchetti · 2011 · Ageing Research Reviews
41. Dairy foods intake and risk of Parkinson’s disease: a dose–response meta-analysis of prospective cohort studies
    Wenjie Jiang, Chuanxia Ju, Hong Fu Jiang, Dongfeng Zhang · 2014 · European Journal of Epidemiology
42. Dietary fat intake, pesticide use, and Parkinson's disease
    Kamel, Freya, Goldman, Samuel M., Umbach, David M., Chen, Honglei, Richardson, Gina, Barber, Marie Richards, Meng, Cheryl, Marras, Connie, Korell, Monica, Kasten, Meike et al. · 2014 · Parkinsonism & Related Disorders
43. Neural effects of gut‐ and brain‐derived glucagon‐like peptide‐1 and its receptor agonist
    Kenichi Katsurada, Toshihiko Yada · 2016 · Journal of Diabetes Investigation
44. Sodium Butyrate Prevents Memory Impairment by Re-Establishing BDNF and GDNF Expression in Experimental Pneumococcal Meningitis
    Barichello, Tatiana, Generoso, Jaqueline S., Simões, Lutiana R., Faller, Cristiano Julio, Ceretta, Renan A., Petronilho, Fabricia, Lopes-Borges, Jéssica, Valvassori, Samira S., Quevedo, João · 2015 · Molecular Neurobiology
45. Intake of dairy foods and risk of Parkinson disease
    Katherine C. Hughes, Xiang Gao, Iris Y. Kim, Molin Wang, Marc G. Weisskopf, Michael A. Schwarzschild, Alberto Ascherio · 2017 · Neurology
46. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson’s disease
    Johnson, Michaela E., Stringer, Andrea, Bobrovskaya, Larisa · 2018 · NeuroToxicology
47. α-Synuclein in Parkinson’s disease: causal or bystander?
    Peter Franz Riederer, Daniela Berg, Nicolas Casadei, Fubo Cheng, Joseph Claßen, Christian Dresel, Wolfgang H. Jost, Rejko Krüger, Thomas H. Müller, Heinz Reichmann et al. · 2019 · Journal of Neural Transmission
48. Prolonged fasting suppresses mitochondrial NLRP3 inflammasome assembly and activation via SIRT3-mediated activation of superoxide dismutase 2
    Javier Traba, Sarah S. Geiger, Miriam A. Osei, Kim Han, One Hyuk Ra, Richard M. Siegel, David R. Gius, Michael N. Sack · 2017 · Journal of Biological Chemistry
49. Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: A systematic review and meta-analysis
    Farzaneh Rahmani, Amene Saghazadeh, Maryam Rahmani, Antônio Lúcio Teixeira, Nima Rezaei, Vajiheh Aghamollaii, Hassan Eftekhar Ardebili · 2018 · Brain Research
50. Objective Colonic Dysfunction is Far more Prevalent than Subjective Constipation in Parkinson’s Disease: A Colon Transit and Volume Study
    Karoline Knudsen, Tatyana Dmitrievna Fedorova, Anne Charlotte Bekker, Peter Iversen, Karen Østergaard, Klaus Krogh, Per Borghammer · 2017 · Journal of Parkinson s Disease
51. Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease
    Peng Feng, Xiangjian Zhang, Dongfang Li, Chenhui Ji, Ziyue Yuan, Ruifang Wang, Guofang Xue, Guanglai Li, Christian Hölscher · 2018 · Neuropharmacology
52. DPP-4 Inhibitors Repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 Receptor in Macrophages Through Protein Kinase C Pathway
    Dai, Yao, Dai, Dongsheng, Wang, Xianwei, Ding, Zufeng, Mehta, Jawahar L. · 2014 · Cardiovascular Drugs and Therapy
53. Gut feelings about smoking and coffee in Parkinson's disease
    Derkinderen, Pascal, Shannon, Kathleen M, Brundin, Patrik · 2014 · Movement Disorders
54. Circadian system — A novel diagnostic and therapeutic target in Parkinson's disease?
    Aleksandar Videnović, Gregory L. Willis · 2016 · Movement Disorders
55. Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice
    Yuki Kishimoto, Wandi S. Zhu, Waki Hosoda, Jyoti Misra Sen, Mark P. Mattson · 2019 · NeuroMolecular Medicine
56. The Search for Environmental Causes of Parkinson’s Disease: Moving Forward
    Honglei Chen, Beate R. Ritz · 2018 · Journal of Parkinson s Disease
57. Gut-brain and brain-gut axis in Parkinson’s disease models: effects of a uridine and fish oil diet
    Perez-Pardo, Paula, Dodiya, Hemraj B., Broersen, Laus M., Douna, Hidde, van Wijk, Nick, Lopes da Silva, Sofia, Garssen, Johan, Keshavarzian, Ali, Kraneveld, Aletta D. · 2018 · Nutritional Neuroscience
58. Invited Review: From nose to gut – the role of the microbiome in neurological disease
    Jack S. Bell, Jonathan I Spencer, Richard L. Yates, Sydney A. Yee, Benjamin M. Jacobs, Gabriele C. DeLuca · 2018 · Neuropathology and Applied Neurobiology
59. The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson's Disease
    Nicholas G. Norwitz, Michele T. Hu, Kieran Clarke · 2019 · Frontiers in Nutrition
60. Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease
    Dirk W. Luchtman, Q. Meng, Cai Song · 2011 · Behavioural Brain Research
61. Dietary habits and neurological features of Parkinson's disease patients: Implications for practice
    Michela Barichella, Emanuele Cereda, Erica Cassani, Giovanna Pinelli, Laura Iorio, Valentina Ferri, Giulia Privitera, Marianna Pasqua, Angela Valentino, Fatemeh Monajemi et al. · 2016 · Clinical Nutrition
62. M cell-depletion blocks oral prion disease pathogenesis
    David S. Donaldson, Atsushi Kobayashi, Hiroshi Ohno, Hideo Yagita∥, Ifor R. Williams, Neil Andrew Mabbott · 2012 · Mucosal Immunology
63. GLP-1 secretion by microglial cells and decreased CNS expression in obesity
    Kappe, Camilla, Tracy, Linda M, Patrone, Cesare, Iverfeldt, Kerstin, Sjöholm, Åke · 2012 · Journal of Neuroinflammation
64. Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1/NOX4/ROS pathway in H9c2 cells
    Ao Chen, Zhangwei Chen, Yan Xia, Danbo Lu, Xiangdong Yang, Aijun Sun, Yunzeng Zou, Juying Qian, Junbo Ge · 2018 · Biochemical and Biophysical Research Communications
65. A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson′s disease by increasing expression of BNDF
    Chenhui Ji, Guofang Xue, Cao L, Peng Feng, Dongfang Li, Lin Li, Guanglai Li, Christian Hölscher · 2015 · Brain Research
66. Omega-3 fatty acids regulate NLRP3 inflammasome activation and prevent behavior deficits after traumatic brain injury
    Chao Lin, Honglu Chao, Zheng Li, Xiupeng Xu, Yinlong Liu, Zhongyuan Bao, Lijun Hou, Yan Liu, Xiaoming Wang, Yongping You et al. · 2017 · Experimental Neurology
67. Does vagotomy reduce the risk of Parkinson's disease?
    Ole‐Bjørn Tysnes, Line Kenborg, Karen Herlofson, Marianne Steding‐Jessen, Arild Horn, Jørgen H. Olsen, Heinz Reichmann · 2015 · Annals of Neurology
68. Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries
    Alejandra Camacho‐Soto, Anat Gross, Susan Searles Nielsen, Neelendu Dey, Brad Alan Racette · 2018 · Parkinsonism & Related Disorders
69. Gut bacterial composition in a mouse model of Parkinson’s disease
    Perez-Pardo, P., Dodiya, H.B., Engen, P.A., Naqib, A., Forsyth, C.B., Green, S.J., Garssen, J., Keshavarzian, A., Kraneveld, A.D. · 2018 · Beneficial Microbes
70. Administration of DHA Reduces Endoplasmic Reticulum Stress-Associated Inflammation and Alters Microglial or Macrophage Activation in Traumatic Brain Injury
    Lloyd D. Harvey, Yan Yin, Insiya Y. Attarwala, Gulnaz Begum, Julia Deng, Hong Qu Yan, C. Edward Dixon, Dandan Sun · 2015 · ASN NEURO
71. Inhibition of NLRP3 Inflammasome Pathway by Butyrate Improves Corneal Wound Healing in Corneal Alkali Burn
    Fang Bian, Yangyan Xiao, Mahira Zaheer, Eugene A. Volpe, Stephen Carl Pflugfelder, De‐Quan Li, Cintia Sade de Paiva · 2017 · International Journal of Molecular Sciences
72. Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease
    Dilan S. Athauda, Thomas Foltynie · 2017 · Neuropharmacology
73. The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function
    Mihaila, Dragos, Donegan, Jordan, Barns, Sarah, LaRocca, Daria, Du, Qian, Zheng, Danny, Vidal, Michael, Neville, Christopher, Uhlig, Richard, Middleton, Frank A. · 2019 · PLOS ONE
74. Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin‐1β administrations: effects of omega‐3 fatty acid EPA treatment
    Pornnarin Taepavarapruk, Cai Song · 2009 · Journal of Neurochemistry
75. The Gut and Parkinson’s Disease: Hype or Hope?
    Filip Scheperjans, Pascal Derkinderen, Per Borghammer · 2018 · Journal of Parkinson s Disease
76. Alcohol, microbiome, and their effect on psychiatric disorders
    Thomas Hillemacher, Oliver P. Bachmann, Kai G. Kahl, Helge Frieling · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
77. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB
    Run Yan, Jie Zhang, Hye-Jin Park, Eun Su Park, Stephanie E. Oh, Haiyan Zheng, Eunsung Junn, Michael V. Voronkov, Jeffry B. Stock, M. Maral Mouradian · 2018 · Proceedings of the National Academy of Sciences
78. Alcohol consumption and the incidence of Parkinson's disease
    Miguel Ángel Hernán, Honglei Chen, Michael A. Schwarzschild, Alberto Ascherio · 2003 · Annals of Neurology
79. Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy
    Lucia Rota, Carolina Pellegrini, Laura Benvenuti, Luca Antonioli, Matteo Fornai, Corrado Blandizzi, Antonino Cattaneo, Emanuela Colla · 2019 · Translational Neurodegeneration
80. Ghrelin is neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic neuroprotection
    Jacqueline A. Bayliss, Zane Bruce Andrews · 2013 · Therapeutic Advances in Endocrinology and Metabolism
81. The interrelationship of metabolic syndrome and neurodegenerative diseases with focus on brain-derived neurotrophic factor (BDNF): Kill two birds with one stone
    Shima Motamedi, Isaac Karimi, Fariba Jafari · 2017 · Metabolic Brain Disease
82. Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits
    Liu, Yuxin, Qin, Liya, Wilson, Belinda, Wu, Xuefei, Qian, Li, Granholm, Ann-Charlotte, Crews, Fulton T., Hong, Jau-Shyong · 2008 · NeuroToxicology
83. Linking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota?
    Scheperjans, Filip, Pekkonen, Eero, Kaakkola, Seppo, Auvinen, Petri · 2015 · Journal of Parkinson’s Disease
84. Models of LRRK2-Associated Parkinson’s Disease
    Yulan Xiong, Ted M. Dawson, Valina Lynn Dawson · 2017 · Advances in neurobiology
85. Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease
    Cansev, Mehmet, Ulus, Ismail H., Wang, Lei, Maher, Timothy J., Wurtman, Richard J. · 2008 · Neuroscience Research
86. Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes
    José A. Santiago, Judith A. Potashkin · 2013 · PLoS ONE
87. Circadian Clocks and Metabolism: Implications for Microbiome and Aging
    Georgios K. Paschos, Garret A. FitzGerald · 2017 · Trends in Genetics
88. Dietary habits in Parkinson's disease: Adherence to Mediterranean diet
    Erica Cassani, Michela Barichella, Valentina Ferri, Giovanna Pinelli, Laura Iorio, Carlotta Bolliri, Serena Caronni, S.A. Faierman, Antonia Mottolese, Chiara Pusani et al. · 2017 · Parkinsonism & Related Disorders
89. Composition and richness of the serum microbiome differ by age and link to systemic inflammation
    Thomas W. Buford, Christy S. Carter, William J. Van Der Pol, Dongquan Chen, Elliot J. Lefkowitz, Peter G. Eipers, Casey D. Morrow, Marcas M. Bamman · 2018 · GeroScience
90. Promising effects of neurorestorative diets on motor, cognitive, and gastrointestinal dysfunction after symptom development in a mouse model of Parkinson's disease
    Perez-Pardo, Paula, de Jong, Esther M., Broersen, Laus M., van Wijk, Nick, Attali, Amos, Garssen, Johan, Kraneveld, Aletta D. · 2017 · Frontiers in Aging Neuroscience
91. NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction
    Luís E. Pavillard, Diego Cañadas-Lozano, Elísabet Alcocer‐Gómez, Fabiola Marín‐Aguilar, Sheila Pereira, Avril A. B. Robertson, Jordi Muntané, Bernhard Ryffel, Matthew A. Cooper, José Luis Quiles et al. · 2017 · Oncotarget
92. Alcohol Consumption and Parkinson’s Disease Risk: A Review of Recent Findings
    Silvana S. Bettiol, Tanith C. Rose, Clarissa J. Hughes, L. A. Smith · 2015 · Journal of Parkinson s Disease
93. Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women
    Natalia Palacios, Xiang Gao, Éilis J. O’Reilly, Michael A. Schwarzschild, Marjorie L. McCullough, Tinisha L. Mayo, Susan M. Gapstur, Alberto Ascherio · 2012 · Movement Disorders
94. Interventions that Improve Body and Brain Bioenergetics for Parkinson's Disease Risk Reduction and Therapy
    Mark P. Mattson · 2014 · Journal of Parkinson s Disease
95. G ut F eelings Ab out α‐ S ynuclein in G astrointestinal B iopsies: B iomarker in the M aking?
    Claudio Ruffmann, Laura Parkkinen · 2016 · Movement Disorders
96. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation
    Yongheng Sui · 2016 · World Journal of Gastroenterology
97. Nutritional habits, risk, and progression of Parkinson disease
    Roberto Erro, Francesco Brigo, Stefano Tamburin, Mauro Musa Zamboni, Angelo Antonini, Michèle Tinazzi · 2017 · Journal of Neurology
98. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson’s disease
    Linfang Chen, Liujun Xue, Jinlong Zheng, Xiangyang Tian, Yingdong Zhang, Qiang Tong · 2018 · Behavioural Brain Research
99. The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson’s disease
    Özlem Özsoy, Yasemin Seval, Gülay Hacıoğlu, Piraye Yargıçoğlu, Ramazan Demir, Ayşel Ağar, Mutay Aslan · 2011 · Neurochemistry International
100. Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
     Paula Perez‐Pardo, Mitch Hartog, Johan Garssen, Aletta D. Kraneveld · 2017 · Current Behavioral Neuroscience Reports
101. Midlife milk consumption and substantia nigra neuron density at death
     Robert D. Abbott, G. Webster Ross, Helen Petrovitch, Kamal Masaki, Lenore J. Launer, James S. Nelson, Lon R. White, Caroline M. Tanner · 2015 · Neurology
102. Inflammasomes: An Emerging Mechanism Translating Environmental Toxicant Exposure Into Neuroinflammation in Parkinson’s Disease
     Faith L. Anderson, Madeleine Coffey, Brent L. Berwin, Matthew C. Havrda · 2018 · Toxicological Sciences
103. What Is the Evidence that Parkinson’s Disease Is a Prion Disorder, Which Originates in the Gut?
     Małgorzata Kujawska, Jadwiga Jodynis‐Liebert · 2018 · International Journal of Molecular Sciences
104. Inhibition of the Inflammasome NLRP3 by Arglabin Attenuates Inflammation, Protects Pancreatic β-Cells from Apoptosis, and Prevents Type 2 Diabetes Mellitus Development in ApoE2Ki Mice on a Chronic High-Fat Diet
     Amna Abderrazak, Khadija El Hadri, Elodie Bosc, Bertrand Blondeau, Mohamed-Naceur Slimane, Berthold Büchele, Thomas Simmet, Dominique Couchie, Mustapha Rouis · 2016 · Journal of Pharmacology and Experimental Therapeutics
105. Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices
     Qingjia Meng, Dirk W. Luchtman, Bouchaı̈b El Bahh, Jeffrey A. Zidichouski, Jun Yang, Cai Song · 2010 · European Journal of Pharmacology
106. A systematic review of nutritional risk factors of Parkinson's disease
     Lianna Ishihara, Carol Brayne · 2005 · Nutrition Research Reviews
107. Reduced brain insulin signaling: A seminal process in Alzheimer's disease pathogenesis
     Bloom, George S., Lazo, John S., Norambuena, Andrés · 2018 · Neuropharmacology
108. Editor’s Highlight: Organophosphate Diazinon Altered Quorum Sensing, Cell Motility, Stress Response, and Carbohydrate Metabolism of Gut Microbiome
     Bei Gao, Xiaoming Bian, Liang Chi, Pengcheng Tu, Hongyu Ru, Kun Lü · 2017 · Toxicological Sciences
109. Regulation of glucagon‐like peptide‐1 sensitivity by gut microbiota dysbiosis
     Shunsuke Yamane, Nobuya Inagaki · 2017 · Journal of Diabetes Investigation
110. The impact of indigenous microbes on Parkinson's disease
     Timothy Robert Sampson · 2019 · Neurobiology of Disease
111. Microbiome and Longevity: Gut Microbes Send Signals to Host Mitochondria
     Jan Gruber, Brian Keith Kennedy · 2017 · Cell
112. Omega‐3 fatty acid eicospentaenoic acid attenuates MPP +‐induced neurodegeneration in fully differentiated human SH ‐ SY 5Y and primary mesencephalic cells
     Dirk W. Luchtman, Qingjia Meng, Xiaofeng Wang, Di Shao, Cai Song · 2012 · Journal of Neurochemistry
113. Triggering of inflammasome by impaired autophagy in response to acute experimental Parkinson’s disease
     Sabrina Giacoppo, Placido Bramanti, Emanuela Mazzon · 2017 · Neuroreport
114. BDNF in the Aged Brain: Translational Implications for Parkinson's Disease.
     Natosha M. Mercado, Timothy J. Collier, Caryl E. Sortwell, Kathy Steece‐Collier · 2017 · PubMed
115. α-Synuclein, alcohol use disorders, and Parkinson disease: A case–control study
     Laura Brighina, Nicole K. Schneider, Timothy G. Lesnick, Mariza de Andrade, Julie M. Cunningham, David A. Mrazek, Walter A. Rocca, Demetrius M. Maraganore · 2009 · Parkinsonism & Related Disorders
116. Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury
     Emilie Cornille, Mhamad Abou-Hamdan, Michel Khrestchatisky, André L. Nieoullon, Max L. De Reggi, Bouchra Gharib · 2010 · BMC Neuroscience
117. An Integrated Review of Psychological Stress in Parkinson’s Disease: Biological Mechanisms and Symptom and Health Outcomes
     Kim Wieczorek Austin, Suzanne Ameringer, Leslie Jameleh Cloud · 2016 · Parkinson s Disease
118. Gut Feelings on Parkinson's and Depression.
     Timothy G. Dinan, John F. Cryan · 2017 · PubMed Central
119. Erratum to: Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients
     Janis R. Bedarf, Falk Hildebrand, Luis Pedro Coelho, Sinichi Sunagawa, Mohammad Bahram, Felix Goeser, Peer Bork B, Ullrich Wüllner · 2017 · Genome Medicine
120. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-κB-mediated CX3CL1/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation
     Jun Ren, Shanshan Meng, Bingdi Yan, Jinyan Yu, JING LIU · 2016 · Molecular Medicine Reports
121. Vertebrate food products as a potential source of prion-like α-synuclein
     Bryan A. Killinger, Viviane Labrie · 2017 · npj Parkinson s Disease
122. Differences in Parkinson’s Disease Risk with Caffeine Intake and Postmenopausal Hormone Use
     Iris Y. Kim, Éilis J. O’Reilly, Katherine C. Hughes, Xiang Gao, Michael A. Schwarzschild, Alberto Ascherio · 2017 · Journal of Parkinson s Disease
123. Editors' Note: The 200th A nniversary of the S haking P alsy
     Jose Angel Obeso, A. Jon Stoessl, María Stamelou · 2017 · Movement Disorders
124. Parkinson’s Disease: No Milk Today?
     Andrea Kistner, Paul Krack · 2014 · Frontiers in Neurology
125. Classifying Aging As a Disease: The Role of Microbes
     Michael S. Lustgarten · 2016 · Frontiers in Genetics
126. LAG3 facilitates cell-to-cell spread of α-synuclein pathology
     Heather B. Wood · 2016 · Nature Reviews Neurology
127. Nutrition and Gastrointestinal Health as Modulators of Parkinson’s Disease
     Heather Elizabeth Rasmussen, Bryana Piazza, Christopher B. Forsyth, Ali Keshavarzian · 2014 · AAPS advances in the pharmaceutical sciences series
128. Untitled work
     1999 · 10.1002/(sici)1097-4547(19990715)57:2